MedPath

Cellulite and Extracorporeal Shock Wave

Not Applicable
Completed
Conditions
Cellulite
Microcirculation
Interventions
Device: Extracorporeal shockwave therapy
Device: Sham extracorporeal shock wave plus gluteal strength exercise
Registration Number
NCT00947414
Lead Sponsor
Hannover Medical School
Brief Summary

Hypothesis: The combination of extracorporeal shockwave and a daily gluteal muscle strength programme is superior to the gluteal muscle strength programme alone in cellulite.

Study design: Randomized-controlled trial

Analysis: Intention-to-treat

Outcome parameters: a) Photo, b) Nürnberger Score, c) circumference measurements, d) capillary blood flow, e) tissue oxygen saturation, f) postcapillary venous blood flow

Intervention: Extracorporeal shock wave for six sessions with 2000 impulses at both gluteal and thigh regions plus a specific gluteal strength exercise training

Follow-up: 12 weeks

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria

Females ages 18-65yrs Cellulite 1°-4° Informed consent

Exclusion Criteria

Pregnancy Open wounds Females >18yrs or >65yrs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Shockwave plus strength trainingExtracorporeal shockwave therapy6 sessions of extracorporeal shock wave plus daily gluteal strength exercises
Sham extracorporeal shock wave plus gluteal strength exerciseSham extracorporeal shock wave plus gluteal strength exerciseSHAM extracorporeal shock wave plus gluteal strength exercise
Primary Outcome Measures
NameTimeMethod
Nuernberger Score based on photo of cellulite12 weeks
Secondary Outcome Measures
NameTimeMethod
Circumference of thigh in cm12 weeks
Capillary blood flow12 weeks
Tissue oxygen saturation12 weeks
Postcapillary venous filling pressure12 weeks

Trial Locations

Locations (1)

Plastic, Hand and Reconstructive Surgery, Hannover Medical School

🇩🇪

Hannover, Germany

© Copyright 2025. All Rights Reserved by MedPath